Zagat gets poor reviews from potential suitors


Back in January, Zagat Survey looked for a buyer. Apparently, the cofounders -- Tim and Nina Zagat – wanted to get $200 million (hey, who wouldn't?). But, with the credit crunch, it did look somewhat optimistic even though the company has a great brand.

Well, the Zagat's investment bank, Goldman Sachs (NYSE: GS), wasn't able to get any buyers at the proposed valuation. I guess there just wasn't enough conviction that Zagat could leverage its dot-com/mobile platform.

Actually, if Zagat attempted a sale a year before, things might have been much different. But, instead the company will need to wait until markets bubble up again, which may take awhile.

Tom Taulli is the author of various books, including The Complete M&A Handbook and The Edgar Online Guide to Decoding Financial Statements. He also operates MergerBook.com.

Symbol Lookup
IndexesChangePrice
DJIA-111.8612,778.60
NASDAQ-17.672,909.56
S&P 500-9.591,342.36

Last updated: February 10, 2012: 01:22 PM

Hot Stocks

General Electric

18.905-0.225(-1.18)

Alcoa

10.325-0.315(-2.96)

Apple Inc

494.81+1.64(+0.33)

Google Inc 'A'

606.855-4.605(-0.75)

Bank of America

8.095-0.085(-1.04)

Wal-Mart Stores

61.50-0.46(-0.74)

Exxon Mobil Corp

83.73-1.15(-1.35)

Ford

12.41-0.28(-2.21)

Citigroup

32.92-0.74(-2.20)

IBM

191.84-1.29(-0.67)

Yahoo

16.255+0.255(+1.59)

Starbucks

48.89-0.31(-0.63)

Microsoft

30.575-0.195(-0.63)

Home Depot

45.265-0.005(-0.01)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

DailyFinance BlackBerry App

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

BioHealth Investor Headlines

Page Loaded in 1328898157344 ms.